Published online before print February 8, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
–/– mice stimulated with interleukin-12 are deficient in production of interferon-



,1
* Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts; USA; and
Department of Inflammation, Wyeth Research, Cambridge, Massachusetts, USA
1Correspondence: Wyeth Research, 200 Cambridge Park Dr., Cambridge, MA 02140, USA. E-mail: mkasaian{at}wyeth.com
Protein kinase C
(PKC
) is expressed in NK cells, but its functional role has not been defined. Here, we demonstrate involvement of PKC
in IL-12-induced NK cell IFN-
production. NK cells from PKC
–/– mice produced less IFN-
in response to IL-12 than those from wild-type (WT) mice. IL-12-induced NK cell cytotoxicity was unaffected, and NK cells from PKC
–/– mice did not display reduced IFN-
production in response to IL-18, indicating a specific role for PKC
in IL-12-induced IFN-
production. Under the conditions tested, T cells did not produce IFN-
in response to IL-12 or affect the ability of NK cells to produce the cytokine. PKC
deficiency did not affect NK cell numbers, granularity, viability, or cytotoxic activity in response to polyinosinic:polycytydylic acid. NK cells from PKC
–/– mice exhibited normal expression of IL-12Rβ1 and STAT4 proteins and normal induction of STAT4 phosphorylation in response to IL-12. Phosphorylation of threonine 538 within the catalytic domain of PKC
was detectable in NK cells from WT mice but was not enhanced by IL-12. Transcription of IFN-
increased similarly in NK cells from WT and PKC
–/– mice in response to IL-12, and there was no difference in IFN-
mRNA stability. Taken together, these findings indicate a role for PKC
in the post-transcriptional regulation of IL-12-induced IFN-
production.
Key Words: cytokines kinases
This article has been cited by other articles:
![]() |
J. I. Aguilo, J. Garaude, J. Pardo, M. Villalba, and A. Anel Protein Kinase C-{theta} Is Required for NK Cell Activation and In Vivo Control of Tumor Progression J. Immunol., February 15, 2009; 182(4): 1972 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tassi, M. Cella, R. Presti, A. Colucci, S. Gilfillan, D. R. Littman, and M. Colonna NK cell-activating receptors require PKC-{theta} for sustained signaling, transcriptional activation, and IFN-{gamma} secretion Blood, November 15, 2008; 112(10): 4109 - 4116. [Abstract] [Full Text] [PDF] |
||||